Hepatitis C

Top Story

EXPEDITION-8: Mavyret nearly perfect in 8-week regimen

November 13, 2018
Meeting News

NS5A substitutions affect early HCV treatment failures, retreatment

November 12, 2018
SAN FRANCISCO — NS5A resistance-associated substitutions at several positions, including Y93, may hold information about DAA treatment response, according to data…
Meeting News

HBV rates rising in women from same U.S. regions with drug-related HCV

November 12, 2018
SAN FRANCISCO — U.S. states in the Appalachian region demonstrated increased rates of hepatitis B among women despite overall national rates of acute and chronic…
Meeting News

DAAs reduce HCC, decompensation risk compared with no treatment

November 12, 2018
SAN FRANCISCO — Individuals with hepatitis C who underwent DAA therapy experienced significant reductions in both hepatocellular carcinoma and decompensation risk…
More Headlines »
CME CE CNE CPE CPE

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

This is a 1 hour activity designed for home study by healthcare clinicians. Specifically, it meets the 1 hour HIV/AIDS…
More »
Meeting News

Mavyret SVR high in patients with Sovaldi, NS5A inhibitor experience

November 11, 2018
SAN FRANCISCO — Mavyret was highly effective and well-tolerated in patients with chronic hepatitis C genotype 1…
More »
Video
Meeting News

VIDEO: Women increase presence at conference

March 8, 2018
More »